メディア（記事）
ログイン
Menu
APIC GUIDANCE ON ASPECTS OF CLEANING VALIDATION IN ACTIVE PHAERMACEUTICAL INGREDIENT PLANTS (2021)
投稿ナビゲーション
Previous
Previous post:
PIC/S-GMP, GUIDELINE ON SETTING HEALTH-BASED EXPOSURE LIMITS FOR USE IN RISK IDENTIFICATION IN THE MANUFACTURE OF DIFFERENT MEDICINAL PRODUCTS IN SHARED FACILITIES (2014)
Next
Next post:
ISPE Baseline🄬 Guide: Risk-Based Manufacture of Pharmaceutical Products (Risk-MaPP) (2010)
